Evidence map›Paper›PMID 19533806›Full record

ReviewWorld journal of gastroenterology2009

CD74 in antigen presentation, inflammation, and cancers of the gastrointestinal tract.

Ellen J Beswick, Victor E Reyes

Open access · hybridAbstract readReview
In one paragraph

Review in World journal of gastroenterology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 131 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. PDGF-D-induced immunoproteasome activation and cell-cell interactions.Computational and structural biotechnology journal · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 3 countries.

Ellen J BeswickDepartment of Pediatrics, Children's Hospital, University of Texas Medical Branch, Galveston, TX 77555, United States. ejbeswic@utmb.edu
Victor E Reyes
The University of Texas Medical Branch at Galveston · USUniversity of Pisa · IT

Funding

IMPAIRED TUMOR IMMUNITY DURING H PYLORI INFECTIONR01DK050669 · NIDDK · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI REYES, VICTOR E · 1995 to 2003
$1.1M
Potential Role of H. Pylori-induced MIF in Gastric CancerK22AI068712 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI BESWICK, ELLEN J. · 2008 to 2009
$269k
NIAID NIH HHS K22 AI068712NIAID NIH HHS K22AI068712NIDDK NIH HHS R01 DK050669
6 · The paper itself

Abstract

CD74 is a protein whose initial role in antigen presentation was recognized two decades ago. Recent studies have revealed that it has additional functions as a receptor for macrophage migration inhibitory factor and as a receptor for an important human pathogen, Helicobacter pylori (H pylori). The role of CD74 as a receptor is important because after binding of migration inhibitory factor or H pylori, NF-kappaB and Erk1/2 activation occurs, along with the induction of proinflammatory cytokine secretion. This review provides an up-to-date account of the functions of CD74 and how it might be involved in inflammation and cancer within the gastrointestinal tract.

Indexed as

Antigen PresentationAntigens, Differentiation, B-LymphocyteGastrointestinal NeoplasmsHelicobacter InfectionsHelicobacter pyloriHistocompatibility Antigens Class IIHumansInflammationInterleukin-8Macrophage Migration-Inhibitory FactorsProtein IsoformsSignal TransductionAntigens, Differentiation, B-LymphocyteHistocompatibility Antigens Class IIInterleukin-8invariant chainMacrophage Migration-Inhibitory FactorsProtein Isoforms

Identifiers

PMID19533806
PMCPMC2699002
OpenAlexW2163063781

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.